--Agilent Technologies Guides For Q4 EPS of $1.38-$1.42 on Revenue of $1.641-$1.691 Billion, vs CIQ Analyst Consensus of $1.44/Share on Revenue of $1.67 Billion-March 2024-www.financetom.com

--Agilent Technologies Guides For Q4 EPS of $1.38-$1.42 on Revenue of $1.641-$1.691 Billion, vs CIQ Analyst Consensus of $1.44/Share on Revenue of $1.67 Billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Agilent Technologies Guides For Q4 EPS of $1.38-$1.42 on Revenue of $1.641-$1.691 Billion, vs CIQ Analyst Consensus of $1.44/Share on Revenue of $1.67 Billion

Aug 22, 2024 1:41 AM

04:08 PM EDT, 08/21/2024 (MT Newswires) --

Price: 143.50, Change: +3.51, Percent Change: +2.51

Previous page： Moonshot firm ispace upbeat as Trump keeps Artemis lunar missions with Japan Next page： Zurn Elkay Water Solutions Prices Common Shares Offering by Selling Stockholder

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Moonshot firm ispace upbeat as Trump keeps Artemis lunar missions with Japan

Feb 12, 2025

TOKYO (Reuters) - Tokyo-based moon exploration company ispace is heartened by signs the United States and Japan will remain on course for joint lunar missions, its CEO said on Wednesday, amid growing uncertainties in U.S. space policies under Trump 2.0. The view by ispace chief executive Takeshi Hakamada came after a meeting last weekend between U.S. President Donald Trump and...

Zurn Elkay Water Solutions Prices Common Shares Offering by Selling Stockholder

Feb 12, 2025

04:19 AM EST, 02/12/2025 (MT Newswires) -- Zurn Elkay Water Solutions ( ZWS ) said late Tuesday it priced an underwritten public offering of about 7.8 million of its common shares launched by former stockholder Ice Mountain at $35 apiece. The company has granted the underwriters a 30-day option to buy up to an additional 1.2 million of its common...

MaxCyte Licenses Cell-Engineering Technology to TG Therapeutics

Feb 12, 2025

04:16 AM EST, 02/12/2025 (MT Newswires) -- MaxCyte ( MXCT ) said Wednesday it is licensing its cell-engineering technology to TG Therapeutics ( TGTX ) . Financial terms were not disclosed. Under the terms of the agreement, TG Therapeutics ( TGTX ) will gain non-exclusive research, clinical and commercial rights to use MaxCyte's ( MXCT ) Flow Electroporation technology and...

Aureus Greenway Holdings Prices $15 Million Initial Public Offering

Feb 12, 2025

03:56 AM EST, 02/12/2025 (MT Newswires) -- Aureus Greenway Holdings said late Tuesday that it has priced an initial public offering of 3.8 million shares at $4.00 per share for a total of $15 million of gross proceeds. The shares are expected to begin Nasdaq trading on Wednesday under the ticker symbol AGH. The offering is expected to close Thursday,...